Literature DB >> 22539365

The prevalence of priapism in children and adolescents with sickle cell disease in Brazil.

Paulo Sampaio Furtado1, Milena Paiva Costa, Flávia Ribeiro do Prado Valladares, Leandro Oliveira da Silva, Maurício Lordêlo, Isa Lyra, Ubirajara Barroso.   

Abstract

To evaluate priapism rates in individuals <18 years of age with sickle cell disease (SCD) at a referral center. An evaluation was made of 599 consecutive male patients with SCD, separated according to type of hemoglobinopathy (HbSS, HbSC and HbS-β-thalassemia). Age at first episode and number of episodes were recorded. Cases of sickle cell trait were excluded. Mean age was similar in all groups. Overall, priapism occurred in 3.6 % of patients (5.6 % of those with HbSS and 1.1 % of those with HbSC; P = 0.01). In HbSS patients, the prevalence rate of priapism was from 3.5 (CI 95 % 0.94-13.4) when compared with patients with HbSC. No patient with β-thalassemia had priapism. Mean follow-up was 39.7 months (range 1-202 months). Since 91 % of patients with priapism had HbSS, this group was evaluated separately, revealing a rate of priapism of 1.6 % in patients <10 years and 8.3 % in those ≥ 10 years of age (P = 0.002). Regarding priapism in HbSS patients ≥ 10 years (8.3 %) when compared with patients <10 years (1.6 %), the prevalence rate was from 3.3 (CI 95 % 1.1-9.5). Duration of follow-up was not correlated with priapism (P = 0.774). Forty-seven patients were lost to follow-up. Telephone contact was successful with 14/22 patients with priapism, 50 % of whom had required hospital treatment. Most episodes (86 %) occurred at night, always during sleep. Medical interventions were required in 13 cases as follows: intravenous hydration (n = 4), corpora cavernosa puncture and drainage (n = 7) and corpus cavernosum-corpus spongiosum shunts (n = 2). The prevalence of priapism in children <18 years of age with SCD was 3.6 %, lower than previously reported. Prevalence was higher in HbSS patients, increasing in patients >10 years of age. Most episodes occurred at night and half of the patients required some form of urological procedure.

Entities:  

Mesh:

Year:  2012        PMID: 22539365     DOI: 10.1007/s12185-012-1083-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  11 in total

1.  Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study.

Authors:  A B Adeyoju; A B K Olujohungbe; J Morris; A Yardumian; D Bareford; A Akenova; O Akinyanju; K Cinkotai; P H O'Reilly
Journal:  BJU Int       Date:  2002-12       Impact factor: 5.588

2.  Prevalence of priapism in children and adolescents with sickle cell anemia.

Authors:  E Mantadakis; J D Cavender; Z R Rogers; D H Ewalt; G R Buchanan
Journal:  J Pediatr Hematol Oncol       Date:  1999 Nov-Dec       Impact factor: 1.289

3.  Beta-globin gene cluster haplotypes and alpha-thalassemia in sickle cell disease patients from Trinidad.

Authors:  Altheia Jones-Lecointe; Erskine Smith; Marc Romana; Marie-Georges Gilbert; Waveney P Charles; Christian Saint-Martin; Lisiane Kéclard
Journal:  Am J Hum Biol       Date:  2008 May-Jun       Impact factor: 1.937

4.  Adhesion of sickle red cells to endothelium: myths and future directions.

Authors:  R P Hebbel
Journal:  Transfus Clin Biol       Date:  2008-05-23       Impact factor: 1.406

5.  Priapism in sickle cell anemia in Togo: prevalence and knowledge of this complication.

Authors:  A D Gbadoé; A Dogba; A Y Ségbéna; M Nyadanu; Y Atakouma; K Kusiaku; A Vovor; J K Assimadi
Journal:  Hemoglobin       Date:  2001-11       Impact factor: 0.849

Review 6.  Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review.

Authors:  A Ashley-Koch; Q Yang; R S Olney
Journal:  Am J Epidemiol       Date:  2000-05-01       Impact factor: 4.897

7.  Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients.

Authors:  Darleen R Powars; Linda S Chan; Alan Hiti; Emily Ramicone; Cage Johnson
Journal:  Medicine (Baltimore)       Date:  2005-11       Impact factor: 1.889

8.  Care of the child with sickle cell disease: acute complications.

Authors:  L D Jakubik; M Thompson
Journal:  Pediatr Nurs       Date:  2000 Jul-Aug

9.  beta-Thalassemia in American Blacks: novel mutations in the "TATA" box and an acceptor splice site.

Authors:  S E Antonarakis; S H Irkin; T C Cheng; A F Scott; J P Sexton; S P Trusko; S Charache; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

10.  Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae.

Authors:  J E Fowler; M Koshy; M Strub; S K Chinn
Journal:  J Urol       Date:  1991-01       Impact factor: 7.450

View more
  4 in total

1.  Clinical and Genetic Predictors of Priapism in Sickle Cell Disease: Results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study.

Authors:  Mina Cintho Ozahata; Grier P Page; Yuelong Guo; João Eduardo Ferreira; Carla Luana Dinardo; Anna Bárbara F Carneiro-Proietti; Paula Loureiro; Rosimere Afonso Mota; Daniela O W Rodrigues; André Rolim Belisario; Claudia Maximo; Miriam V Flor-Park; Brian Custer; Shannon Kelly; Ester Cerdeira Sabino
Journal:  J Sex Med       Date:  2019-10-24       Impact factor: 3.802

Review 2.  Management of refractory ischemic priapism: current perspectives.

Authors:  Marco Capece; Arianna Gillo; Andrea Cocci; Giulio Garaffa; Massimiliano Timpano; Marco Falcone
Journal:  Res Rep Urol       Date:  2017-08-29

3.  Prevalence of priapism in individuals with sickle cell disease and implications on male sexual function.

Authors:  Mateus Andrade Alvaia; Heros Aureliano Antunes da Silva Maia; Alana de Medeiros Nelli; Carina Oliveira Silva Guimarães; Evanilda Souza de Santana Carvalho; José Murillo Bastos Netto; Eduardo de Paula Miranda; Cristiano Mendes Gomes; José de Bessa Júnior
Journal:  Einstein (Sao Paulo)       Date:  2020-04-22

4.  Priapism Followed by Discontinuation of Methadone: A rare Case Report.

Authors:  Seyed-Ali Mostafavi; Reza Bidaki
Journal:  Iran J Psychiatry       Date:  2015-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.